Santen Pharmaceutical Q1 EPS $0.11 Misses $0.12 Estimate, Sales $431.325M Beat $418.770M Estimate
Santen Pharmaceutical (OTC:SNPHY) reported quarterly earnings of $0.11 per share which missed the analyst consensus estimate of $0.12 by 8.33 percent. This is a 8.33 percent decrease over earnings of $0.12 per share
Santen made a tiny bit less profit per share than experts predicted, even though they sold more products than expected. When a company sells more but earns less per share, it hints that their costs went up or something else made profits smaller.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.